BAC
Bank of America Corporation
BAC has the edge over RLI overall, supported by stronger modeled upside and stronger fundamentals.
RLI
RLI Corp.
RLI trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RLI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
RLI's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like RLI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RLI in the historical PE scenario, which offers more potential upside but is not a forecast.
RLI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $51.93 | -25% |
| Current | 16x | $69.12 | — |
| Fair | 19x | $81.55 | +18% |
| Forward | 25x | $69.12 | — |
| Expensive | 31x | $134 | +94% |
Historical ranges are pointers, not guarantees.
RLI's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 25x, in its expensive range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over RLI on the outlook, with more favorable valuation and earnings expectations.
RLI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect RLI's profitability to weaken, with its earnings and revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over RLI on earnings, with more consistent year-over-year improvement.
RLI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.73 | -36% |
| Q3 2026 | $4.30 | +13% |
| Q2 2026 | $4.77 | +37% |
| Q1 2026 | $4.29 | +41% |
| Q4 2025 | $4.37 | +17% |
| Q3 2025 | $3.81 | -16% |
| Q2 2025 | $3.49 | -4.6% |
| Q1 2025 | $3.04 | -16% |
| Q4 2024 | $3.74 | +13% |
RLI's earnings per share have fallen from their peak: $4.30 over the past year, against $7.79 in mid-2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over RLI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over RLI on profitability, with a higher operating margin.
RLI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $477M | -6.3% |
| Q2 2026 | $575.6M | +15% |
| Q1 2026 | $423.9M | +4% |
| Q4 2025 | $465.7M | +6.1% |
| Q3 2025 | $509.3M | +8.4% |
| Q2 2025 | $499.8M | +20% |
| Q1 2025 | $407.7M | -8.4% |
| Q4 2024 | $439.1M | +1.3% |
RLI's revenue is growing: $477M last quarter, down 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -9.9 points |
| Q2 2026 | 37% | +5.3 points |
| Q1 2026 | 16% | -3.4 points |
| Q4 2025 | 24% | +14 points |
| Q3 2025 | 31% | +6 points |
| Q2 2025 | 31% | +6.5 points |
| Q1 2025 | 19% | -17 points |
| Q4 2024 | 11% | -22 points |
RLI's operating margin was 21% last quarter, down 9.9 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RLI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $192.4M | +8.2% |
| Q2 2026 | $142.4M | -18% |
| Q1 2026 | $41.8M | -59% |
| Q4 2025 | $155M | +21% |
| Q3 2025 | $177.8M | -19% |
| Q2 2025 | $173.4M | +25% |
| Q1 2025 | $102.5M | +47% |
| Q4 2024 | $127.6M | +4.9% |
RLI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RLI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RLI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +91K shares |
| 1 year | -0.1% | -59K shares |
| 3 years | +0.1% | +121K shares |
| 5 years | +1% | +873K shares |
| Available history | +1.9% | +1.7M shares |
RLI has 92M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.3M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RLI Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RLI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 82.5 | Overbought |
RLI's weekly RSI is 65 (neutral) and its Stochastic is 83 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over RLI on valuation relative to its sector.
RLI PE vs Financial Services Sector
| Metric | RLI | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 23% above |
| PE % | 27 | 63 | 36 pts below |
RLI is trading at 16x earnings, a 23% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RLI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.0 | 12% above |
| 20 week MA | $62.2 | 11% above |
| 50 week MA | $59.6 | 16% above |
| 100 week MA | $65.5 | 5.5% above |
| 200 week MA | $68.1 | 1.5% above |
RLI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
RLI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.9 | $51.9 | +16% |
| 2021 | $51.9 | $54.7 | +5.4% |
| 2022 | $54.7 | $66.9 | +22% |
| 2023 | $66.9 | $66.6 | -0.4% |
| 2024 | $66.6 | $83.0 | +25% |
| 2025 | $83.0 | $64.7 | -22% |
| 2026 YTD | $64.7 | $69.1 | +6.8% |
RLI has the edge over BAC on returns for 2026, with the stronger performance.